Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 08 - 12 save search
NK Cell Therapy Developer Quadruples San Diego Footprint
Published: 2021-08-12 (Crawled : 16:00) - biospace.com/
ARE A | $117.935 1.22% 110K
|
Finance
|
| O: -0.12%
H: 0.36%
C: 0.14%
therapy
Artiva Biotherapeutics Establishes U.S. Research and Manufacturing Facility for NK Cell Therapy Pipeline Development and Clinical Supply
Published: 2021-08-12 (Crawled : 13:00) - biospace.com/
ARE A | $117.935 1.22% 110K
|
Finance
|
| O: -0.12%
H: 0.36%
C: 0.14%
AFMD | $5.07 7.8K
|
Health Technology
|
| O: 0.48%
H: 0.48%
C: -0.64%
therapy research iot
Junshi Biosciences and Coherus Announce U.S. FDA Breakthrough Therapy Designation Granted for Toripalimab for 1st Line Treatment of Nasopharyngeal Carcinoma
Published: 2021-08-12 (Crawled : 12:15) - globenewswire.com
ABBV | News | $164.91 0.15% 1.2M
|
Health Technology
|
| O: 0.21%
H: 1.55%
C: 1.47%
CHRS | $1.995 -0.25% 1.4M
|
Health Technology
|
| O: 1.05%
H: 1.26%
C: 0.96%
treatment fda therapy breakthrough therapy grant designation
Sio Gene Therapies Announces Corporate Updates and Fiscal First Quarter 2021 Financial Results
Published: 2021-08-12 (Crawled : 12:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 1.54%
H: 4.04%
C: 3.03%
financial results gene therapies results therapy gene therapy
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.3022 24.82% 51M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.